TCWM
XFOR icon

Total Clarity Wealth Management’s X4 Pharmaceuticals XFOR Stock Holding History

Total Clarity Wealth Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-456
Closed -$19K – 293
2024
Q1 		$19K Buy
+456
New +$12.7K 0.01% 265
2023
Q4 		– Sell
-384
Closed -$12.6K – 255
2023
Q3 		$12.6K Sell
384
-4,467
-92% -$195K 0.01% 218
2023
Q2 		$282K Buy
4,851
+4,484
+1,222% +$230K 0.14% 160
2023
Q1 		$9.57K Buy
+367
New +$10.8K 0.01% 176

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Total Clarity Wealth Management's XFOR Position: Q2 2024 in Review

Total Clarity Wealth Management sold out of X4 Pharmaceuticals (XFOR) in Q2 2024, closing a stake of 456 shares — an estimated $19K sold.

Total Clarity Wealth Management first reported a position in XFOR in Q1 2023 and held it in 4 quarters. The position peaked at $282K in Q2 2023. 98 funds tracked by Wall St. Rank hold XFOR as of Q2 2024.

  • Total Clarity Wealth Management reported no remaining X4 Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Total Clarity Wealth Management sold 456 X4 Pharmaceuticals shares in Q2 2024, an estimated $19K.
  • Total Clarity Wealth Management first reported a position in X4 Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • Total Clarity Wealth Management's X4 Pharmaceuticals position peaked at $282K in Q2 2023.
  • 98 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2024.

Based on Total Clarity Wealth Management's 13F filing for Q2 2024, filed 9 Aug 2024.